🇺🇸 FDA
Pipeline program

ART27.13, Placebo, ART27.13

ART27.13-100

Phase 2 small_molecule active

Quick answer

ART27.13, Placebo, ART27.13 for Cancer Anorexia is a Phase 2 program (small_molecule) at ARTELO BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ARTELO BIOSCIENCES, INC.
Indication
Cancer Anorexia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials